Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Stamulumab> ?p ?o }
Showing triples 1 to 73 of
73
with 100 triples per page.
- Stamulumab abstract "Stamulumab (MYO-029) is an experimental myostatin inhibiting drug developed by Wyeth Pharmaceuticals for the treatment of muscular dystrophy (MD). Stamulumab was formulated and tested by Wyeth in Collegeville, Pennsylvania. Myostatin is a protein that inhibits the growth of muscle tissue, stamulumab is a recombinant human antibody designed to bind to and inhibit the activity of myostatin.Stamulumab is a G1 immunoglobulin antibody which binds to myostatin and prevents it from binding to its target site, thus inhibiting the growth-limiting action of myostatin on muscle tissue. Research completed in 2002 found that Stamulumab might one day prove to be an effective treatment for Duchenne muscular dystrophy".
- Stamulumab atcPrefix "none".
- Stamulumab casNumber "705287-60-1".
- Stamulumab fdaUniiCode "V43X8G4797".
- Stamulumab wikiPageID "9701299".
- Stamulumab wikiPageLength "4664".
- Stamulumab wikiPageOutDegree "20".
- Stamulumab wikiPageRevisionID "658891210".
- Stamulumab wikiPageWikiLink ACVR2B.
- Stamulumab wikiPageWikiLink Annals_of_Neurology.
- Stamulumab wikiPageWikiLink Antibody.
- Stamulumab wikiPageWikiLink Atomic_mass_unit.
- Stamulumab wikiPageWikiLink Beckers_muscular_dystrophy.
- Stamulumab wikiPageWikiLink Category:Wyeth.
- Stamulumab wikiPageWikiLink Clinical_trial.
- Stamulumab wikiPageWikiLink Cohort_study.
- Stamulumab wikiPageWikiLink Collegeville,_Pennsylvania.
- Stamulumab wikiPageWikiLink Duchenne_muscular_dystrophy.
- Stamulumab wikiPageWikiLink Facioscapulohumeral_muscular_dystrophy.
- Stamulumab wikiPageWikiLink G1_phase.
- Stamulumab wikiPageWikiLink Immunoglobulin.
- Stamulumab wikiPageWikiLink KDa.
- Stamulumab wikiPageWikiLink Limb-girdle_muscular_dystrophy.
- Stamulumab wikiPageWikiLink Muscular_dystrophy.
- Stamulumab wikiPageWikiLink Myostatin.
- Stamulumab wikiPageWikiLink Protein.
- Stamulumab wikiPageWikiLink Recombinant_DNA.
- Stamulumab wikiPageWikiLink Wyeth.
- Stamulumab wikiPageWikiLinkText "Stamulumab".
- Stamulumab wikiPageWikiLinkText "stamulumab".
- Stamulumab atcPrefix "none".
- Stamulumab c "6330".
- Stamulumab casNumber "705287".
- Stamulumab chemspiderid "NA".
- Stamulumab h "9748".
- Stamulumab hasPhotoCollection Stamulumab.
- Stamulumab kegg "D05917".
- Stamulumab mabType "mab".
- Stamulumab molecularWeight "137.5".
- Stamulumab n "1672".
- Stamulumab o "1668".
- Stamulumab routesOfAdministration "injection only".
- Stamulumab s "48".
- Stamulumab source "u".
- Stamulumab target Myostatin.
- Stamulumab type "mab".
- Stamulumab unii "V43X8G4797".
- Stamulumab verifiedfields "changed".
- Stamulumab verifiedrevid "470470459".
- Stamulumab wikiPageUsesTemplate Template:Drugbox.
- Stamulumab wikiPageUsesTemplate Template:Monoclonals_for_bone,_musculoskeletal,_circulatory,_and_neurologic_systems.
- Stamulumab wikiPageUsesTemplate Template:Muscular_Dystrophy.
- Stamulumab subject Category:Wyeth.
- Stamulumab hypernym Myostatin.
- Stamulumab type Article.
- Stamulumab type ChemicalSubstance.
- Stamulumab type Company.
- Stamulumab type Drug.
- Stamulumab type Antibody.
- Stamulumab type Article.
- Stamulumab type Chemical.
- Stamulumab type Company.
- Stamulumab type Drug.
- Stamulumab type ChemicalObject.
- Stamulumab type Thing.
- Stamulumab type Q8386.
- Stamulumab comment "Stamulumab (MYO-029) is an experimental myostatin inhibiting drug developed by Wyeth Pharmaceuticals for the treatment of muscular dystrophy (MD). Stamulumab was formulated and tested by Wyeth in Collegeville, Pennsylvania.".
- Stamulumab label "Stamulumab".
- Stamulumab sameAs m.02ppl63.
- Stamulumab sameAs Q7597513.
- Stamulumab sameAs Q7597513.
- Stamulumab wasDerivedFrom Stamulumab?oldid=658891210.
- Stamulumab isPrimaryTopicOf Stamulumab.